Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
2021 · Journal of Experimental & Clinical Cancer Research · 42 citations
https://doi.org/10.1186/s13046-021-02125-z
O
Oxana Schmidt
TUM Klinikum(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
39
Papers
300
Citations
10
h-index
10
i10-index
Oxana Schmidt is an academic researcher from TUM Klinikum. The author has contributed to research in topics: Protein Degradation and Inhibitors & Sarcoma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 10, co-authored 34 publications.
Papers by this author
worksAdditional file 3 of Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.16821781
Additional file 2 of Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.16821778
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat